NO885221L - Estere av farmakologisk aktive karboksylsyrer. - Google Patents

Estere av farmakologisk aktive karboksylsyrer.

Info

Publication number
NO885221L
NO885221L NO88885221A NO885221A NO885221L NO 885221 L NO885221 L NO 885221L NO 88885221 A NO88885221 A NO 88885221A NO 885221 A NO885221 A NO 885221A NO 885221 L NO885221 L NO 885221L
Authority
NO
Norway
Prior art keywords
lower alkyl
group
aryl
carboxylic acids
esters
Prior art date
Application number
NO88885221A
Other languages
English (en)
Norwegian (no)
Other versions
NO885221D0 (no
Inventor
Andre Furlenmeier
Marc Montavon
Christian Hubschwerlen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO885221D0 publication Critical patent/NO885221D0/no
Publication of NO885221L publication Critical patent/NO885221L/no
Priority to NO921057A priority Critical patent/NO921057D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO88885221A 1987-11-24 1988-11-23 Estere av farmakologisk aktive karboksylsyrer. NO885221L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO921057A NO921057D0 (no) 1987-11-24 1992-03-18 7-aminocefalosporinderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH457087 1987-11-24
CH316588 1988-08-25

Publications (2)

Publication Number Publication Date
NO885221D0 NO885221D0 (no) 1988-11-23
NO885221L true NO885221L (no) 1989-05-25

Family

ID=25692354

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885221A NO885221L (no) 1987-11-24 1988-11-23 Estere av farmakologisk aktive karboksylsyrer.

Country Status (14)

Country Link
EP (1) EP0318767A3 (fr)
JP (1) JPH01165585A (fr)
KR (1) KR890008082A (fr)
AU (1) AU614793B2 (fr)
DK (1) DK637888A (fr)
FI (1) FI885330A (fr)
HU (1) HU207522B (fr)
IL (1) IL88403A0 (fr)
MC (1) MC1991A1 (fr)
NO (1) NO885221L (fr)
NZ (1) NZ226989A (fr)
PT (1) PT89080B (fr)
SU (1) SU1598880A3 (fr)
YU (2) YU216188A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL113744A (en) * 1990-11-09 1998-06-15 Eisai Co Ltd History of 3-tufts and their preparation
PL323148A1 (en) * 1995-05-03 1998-03-16 Smithkline Beecham Plc Esters of crabapenemes
KR20140064917A (ko) * 2011-08-31 2014-05-28 말린크로트 엘엘씨 H-포스포네이트-엔/-인 히드로포스포닐화 반응을 이용한 표적화된 나노입자의 원격 어셈블리
EP2862569A1 (fr) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Procédés pour traiter des infections intrapulmonaires
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS5984889A (ja) * 1982-11-05 1984-05-16 Sumitomo Chem Co Ltd セフアロスポリン誘導体およびその製造方法

Also Published As

Publication number Publication date
AU614793B2 (en) 1991-09-12
EP0318767A2 (fr) 1989-06-07
SU1598880A3 (ru) 1990-10-07
YU191589A (en) 1991-02-28
MC1991A1 (fr) 1989-11-30
JPH01165585A (ja) 1989-06-29
HUT48895A (en) 1989-07-28
DK637888D0 (da) 1988-11-15
PT89080B (pt) 1993-04-30
PT89080A (pt) 1988-12-01
FI885330A (fi) 1989-05-25
HU207522B (en) 1993-04-28
NO885221D0 (no) 1988-11-23
IL88403A0 (en) 1989-06-30
YU216188A (en) 1990-04-30
EP0318767A3 (fr) 1991-03-20
FI885330A0 (fi) 1988-11-17
KR890008082A (ko) 1989-07-08
DK637888A (da) 1989-05-25
AU2578588A (en) 1989-05-25
NZ226989A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
NO885221L (no) Estere av farmakologisk aktive karboksylsyrer.
NL960019I1 (nl) Moforlino-ethylester van mycofenolzuur en derivaten ervan, de bereiding ervan en hun toepassing in farmaceutische samenstellingen.
ES8103734A1 (es) Procedimiento para preparar nuevos derivados de piperidina
EP0322926A3 (fr) Essais utilisant des esters, des thioesters et des amides chimioluminescents
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
KR830006287A (ko) 아데닌 뉴클레오시드 유도체의 제조방법
AU8400382A (en) N-substituted azeheterocyclic carboxylic acids and their esters
GB1514389A (en) Glycerides with antibacterial properties
BE895712A (fr) Derives de benzo-1,3-thiazine-1,1-dixoyde, leur preparation et leur utilisation
MY104951A (en) Process for the production of phthalazineacbtic acid ester derivatives and a novel intermediate.
FR2364923A1 (fr) Nouveaux amides d'esters phosphorique, leur procede de preparation et leur application comme insecticides et acaricides
IE44858L (en) HYPOLIPIDEMIC p-AMINOBENZOIC ACIDS
ES8704495A1 (es) Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
FR2378038A1 (fr) Nouveaux amides d'esters d'acides dithiophosphoniques substitues, leur procede de preparation et leur application comme insecticides, acaricides et nematicides
GB1504683A (en) Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives
JPS56140991A (en) Quinuclidine ester and derivative of phenoxycarboxylic acid, manufacture and related pharmaceutical compositions
IE42421L (en) Pharmaceutical compositions
GB1496298A (en) Esters of theophyllinylacetic acid
JPS54106463A (en) Preparation of optically active n-methyl-2-pyrrolidin eethanol
ES430467A1 (es) Procedimiento para la obtencion de esteres de efecto nema- tocida.
ES464250A1 (es) Procedimiento de preparacion de nuevos esteres del acido isobutirico disustituido.
TH7962A (th) เอสเทอร์ของกรดคาร์บอกซิลิคซึ่งออกฤทธิ์ทางเภสัชวิทยาซึ่งแยกตัวได้ภายใต้สภาวะทางสรีระวิทยา
TH7962EX (th) เอสเทอร์ของกรดคาร์บอกซิลิคซึ่งออกฤทธิ์ทางเภสัชวิทยาซึ่งแยกตัวได้ภายใต้สภาวะทางสรีระวิทยา
TH2354EX (th) อนุพันธ์ของไตรคลอโรอาคริลโลอิลออกซึมกระบวนการสำหรับเตรียมสารเหล่านี้และสารกำจัดเชื้อราในการเกษตร
ES356467A1 (es) Procedimiento para la preparacion de 2-tio-1,3-benzoxaci- nas.